Pharma Mirror Magazine

AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus

February 11, 2020

AIM ImmunoTech Inc. (NYSE American:AIM) announced the filing of three provisional patent applications related to its drug candidate Ampligen in

February 10, 2020

PBSC have led the way, providing high quality products and services to pharmaceutical, medical research, high containment and hospital research

February 10, 2020

Introduction of new drugs for rare indications, rising prevalence of chronic diseases, and growing ageing population have increased the consumption

February 7, 2020

The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing

February 6, 2020

Laetus presents a wide range of solutions at this year’s interpack (Düsseldorf, 7 to 13 May, hall 8b/booth D02) for

February 3, 2020

Azelis, a leading distributor of specialty chemicals and food ingredients, is delighted to announce it will acquire 100% of the